Associated tags: KSF, Professional Services, Legal, Class Action Lawsuit, Court, District court, Sale
Locations: CENTRAL DISTRICT, EASTERN, CONNECTICUT, CAMBODIA, CHEVRON, ELLINGTON, TABULA, CRESTWOOD, HAWAII, SUMMIT, CENTRAL VALLEY, BRITISH COLUMBIA, BLACKSTONE, ALASKA, III, CALLON, UNITED STATES, NORTH AMERICA, LOUISIANA, DELAWARE, CALIFORNIA, NEW YORK, TARO, PENNSYLVANIA, ORRSTOWN, HOLLEY, EUROPE, CANADA, UNITED KINGDOM, VIRGINIA, ILLINOIS, GL, HEARTLAND, NEW ORLEANS, LA, US, COLORADO, TENNESSEE, TEXAS, MASSACHUSETTS
and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Shockwave Medical, Inc. (NasdaqGS: SWAV) to Johnson & Johnson (NYSE: JNJ).
Key Points:
- and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Shockwave Medical, Inc. (NasdaqGS: SWAV) to Johnson & Johnson (NYSE: JNJ).
- Under the terms of the proposed transaction, shareholders of Shockwave will receive $335.00 in cash for each share of Shockwave that they own.
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .
and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Southwestern Energy Company (NYSE: SWN) to Chesapeake Energy Corporation (NasdaqGS: CHK).
Key Points:
- and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Southwestern Energy Company (NYSE: SWN) to Chesapeake Energy Corporation (NasdaqGS: CHK).
- Under the terms of the proposed transaction, shareholders of Southwestern will receive 0.0867 shares of Chesapeake for each share of Southwestern that they own.
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Key Points:
- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
- and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Fusion Pharmaceuticals Inc. (NasdaqGS: FUSN) to AstraZeneca.
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Key Points:
- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
- and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of AVROBIO, Inc. (NasdaqGS: AVRO) and Tectonic Therapeutic, Inc. pursuant to which pre-merger AVROBIO shareholders are expected to own approximately 22.3% of the combined company.
- KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Key Points:
- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
- and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inhibrx, Inc. (NasdaqGM: INBX) to Sanofi (NasdaqGS: SNY).
- KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
- To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .
NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 1, 2024 to file lead plaintiff applications in a securities class action lawsuit against Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL), if they purchased or otherwise acquired the Company’s shares between May 8, 2019 and April 10, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 1, 2024 to file lead plaintiff applications in a securities class action lawsuit against Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL), if they purchased or otherwise acquired the Company’s shares between May 8, 2019 and April 10, 2024, inclusive (the “Class Period”).
- Long term holders of GL are also encouraged to contact the firm.
- This action is pending in the United States District Court for the Eastern District of Texas.
- If you wish to serve as a lead plaintiff in this class action, you must petition the Court by July 1, 2024.
NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 24, 2024 to file lead plaintiff applications in a securities class action lawsuit against Autodesk, Inc. (NasdaqGS: ADSK), if they purchased or otherwise acquired the Company’s securities between June 1, 2023 and April 16, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 24, 2024 to file lead plaintiff applications in a securities class action lawsuit against Autodesk, Inc. (NasdaqGS: ADSK), if they purchased or otherwise acquired the Company’s securities between June 1, 2023 and April 16, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Northern District of California.
- If you purchased securities of Autodesk and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-adsk/ to learn more.
- If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 24, 2024.
NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero Therapeutics, Inc. (NasdaqGS: AKRO), if they purchased or otherwise acquired the Company’s shares between September 13, 2022 and October 9, 2023, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero Therapeutics, Inc. (NasdaqGS: AKRO), if they purchased or otherwise acquired the Company’s shares between September 13, 2022 and October 9, 2023, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Northern District of California.
- If you purchased shares of Akero and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-akro/ to learn more.
- If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 25, 2024.
NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company’s shares between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company’s shares between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Northern District California.
- If you purchased shares of Doximity and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-docs/ to learn more.
- If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 17, 2024.
NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 20, 2024 to file lead plaintiff applications in securities class action lawsuits against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL), if they: i) purchased or otherwise acquired the Company’s shares between April 15, 2021 and February 27, 2024, inclusive (the “Class Period”), and/or ii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s April 2021 initial public offering (“IPO”), and/or iii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s May 2023 secondary public offering (“SPO”).
Key Points:
- NEW ORLEANS, May 07, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 20, 2024 to file lead plaintiff applications in securities class action lawsuits against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL), if they: i) purchased or otherwise acquired the Company’s shares between April 15, 2021 and February 27, 2024, inclusive (the “Class Period”), and/or ii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s April 2021 initial public offering (“IPO”), and/or iii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s May 2023 secondary public offering (“SPO”).
- These actions are pending in the United States District Courts for the Western District of Texas and Southern District of New York.
- If you purchased or otherwise acquired shares of agilon as above and would like to discuss your legal rights and how these cases might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-agl/ to learn more.
- If you wish to serve as a lead plaintiff in the class actions, you must petition the Courts by May 20, 2024.
